Hear AtLast Holdings, Inc. (HRAL)
0.0003
0.00 (0.00%)
USD |
OTCM |
Sep 25, 16:00
Hear AtLast Holdings Net Income (Quarterly) : -0.2205M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2205M |
| March 31, 2026 | -0.1553M |
| December 31, 2025 | -0.2991M |
| September 30, 2025 | -0.1259M |
| June 30, 2025 | -0.1526M |
| March 31, 2025 | -0.1268M |
| December 31, 2024 | -0.1825M |
| June 30, 2024 | -0.1127M |
| March 31, 2024 | -0.0804M |
| December 31, 2023 | -0.054M |
| September 30, 2023 | -0.0326M |
| June 30, 2023 | -0.0202M |
| March 31, 2023 | -0.0222M |
| December 31, 2022 | -0.0513M |
| September 30, 2022 | -0.1399M |
| June 30, 2022 | -0.0019M |
| March 31, 2022 | -0.2786M |
| December 31, 2021 | -0.0682M |
| September 30, 2021 | -0.0508M |
| June 30, 2021 | -0.1398M |
| March 31, 2021 | -0.0083M |
| December 31, 2020 | -0.0134M |
| September 30, 2020 | -0.3245M |
| June 30, 2020 | -0.0153M |
| March 31, 2020 | -0.5563M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.0665M |
| September 30, 2019 | -0.0876M |
| June 30, 2019 | -0.0008M |
| March 31, 2019 | -0.2066M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | -0.1125M |
| December 31, 2013 | 0.0241M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 928.00M |
| Aethlon Medical, Inc. | -1.548M |
| ABVC BioPharma, Inc. | -0.8105M |
| Adagio Medical Holdings, Inc. | -6.717M |
| Abingdon Health Plc | -- |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.2205M |
| EPS Diluted (Quarterly) | -0.0004 |
| Enterprise Value | 3.922M |
| Earnings Yield | -500.0% |
| Normalized Earnings Yield | -500.00 |